secwatch.observer — SEC 8-K summary
======================================

Issuer:     Larimar Therapeutics, Inc. (LRMR)
CIK:        0001374690
Form:       8-K
Filed at:   2026-01-12T23:59:59+00:00
Accession:  0001193125-26-010409
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 2.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Larimar Therapeutics reports preliminary cash position of $136.9M as of Dec 31, 2025
--------------------------------------------------------------------------------

- Preliminary cash, cash equivalents and marketable securities of $136.9M as of Dec 31, 2025, unaudited.
- Amount is subject to completion of quarter-end and year-end financial close procedures.
- Full year 2025 financial results will be included in the upcoming Form 10-K filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1374690/000119312526010409/0001193125-26-010409-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1374690/000119312526010409/lrmr-20260112.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-010409

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer